###
中国临床研究:2025,38(12):1862-1866
本文二维码信息
码上扫一扫!
酮咯酸氨丁三醇联合舒芬太尼对腹腔镜胆囊切除术患者疼痛及血清应激指标的影响
(黄淮学院附属驻马店市中心医院麻醉科,河南 驻马店 463000)
Effect of ketorolac tromethamine combined with sufentanil on pain and serum stress indicators in patients undergoing laparoscopic cholecystectomy
(Department of Anesthesiology, Zhumadian Central Hospital Affiliated to Huanghuai University, Zhumadian, Henan 463000, China)
摘要
本文已被:浏览 176次   下载 80
投稿时间:2025-03-06   网络发布日期:2025-12-25
中文摘要: 目的 探讨酮咯酸氨丁三醇联合舒芬太尼对腹腔镜胆囊切除术(LC)患者视觉模拟评分(VAS)及血清应 激指标[去甲肾上腺素、皮质醇(Cor)、促肾上腺皮质激素(ACTH)]的影响。方法 回顾性分析2022年12月至 2024年12月于驻马店市中心医院202例行LC患者的临床资料,根据麻醉方案分为两组,采用舒芬太尼镇痛的 为对照组(n=101),采用酮咯酸氨丁三醇联合舒芬太尼镇痛的为试验组(n=101)。对比两组术后4h、8h、12h、24h 的静息及活动时VAS评分,对比两组术前和术后1d、3d、6d时的去甲肾上腺素、Cor、ACTH水平,对比两组术后相关 指标(苏醒时间、自主呼吸恢复时间、舒芬太尼用量、有效按压镇痛泵次数)。结果 试验组术后4h、8h、12h、24h的 活动时VAS评分均低于对照组(P<0.05)。试验组术后1d、3d、6d的Cor、去甲肾上腺素、ACTH水平均低于对照组(P<0.05)。与对照组相比,试验组舒芬太尼用量[(72.63±3.88)μgvs(95.84±5.19)μg,t=35.997,P<0.01]和有效按压镇痛泵次数[(3.22±1.10)次vs(6.85±1.39)次,t=20.581,P<0.01]较少,差异有统计学意义。结论 酮咯酸氨丁三醇联合舒芬太尼可降低LC患者术后疼痛程度,减轻应激反应,减少舒芬太尼用量和镇痛泵使用次数。
Abstract:Objective To investigate the effects of ketorolac tromethamine combined with sufentanil on the Visual Analog Scale (VAS) scores and serum stress indicators [norepinephrine, cortisol (Cor), adrenocorticotropic hormone (ACTH)] in patients undergoing laparoscopic cholecystectomy (LC). Methods A retrospective analysis was conducted on the clinical data of 202 patients who underwent LC at Zhumadian Central Hospital from December 2022 to December 2024. According to the anesthesia regimen, the patients were divided into two groups: control group (n=101, received sufentanil analgesia) and experimental group (n=101, received ketorolac tromethamine combined with sufentanil analgesia). The VAS scores for resting and activity were compared between the two groups at 4 h, 8 h, 12 h, and 24 h after surgery. The levels of norepinephrine, Cor, and ACTH were compared preoperatively and at 1 d, 3 d, and 6 d after surgery. Postoperative indicators such as awakening time, time to restore spontaneous breathing, sufentanil dosage, and effective analgesia pump presses were also compared between the two groups. Results The VAS scores for activity at 4 h, 8 h, 12 h, and 24 h after surgery were lower in the experimental group than those in the control group (P<0.05). The levels of Cor, norepinephrine, and ACTH at 1 d, 3 d, and 6 d after surgery were also lower in experimental group (P<0.05). Compared to control group, the experimental group used less sufentanil [ (72.63±3.88) μg vs (95.84±5.19) μg, t=35.997, P<0.01]and had fewer effective analgesia pump presses [ (3.22±1.10) times vs (6.85±1.39) times, t=20.581, P<0.01], with statistically significant differences. Conclusion Ketorolac tromethamine combined with sufentanil can reduce postoperative pain, alleviate the stress response, and decrease sufentanil usage and analgesia pump presses in LC patients.
文章编号:     中图分类号:R614 R657.4    文献标志码:A
基金项目:
附件
引用文本:
陈丹迪,吴黎生,赵勇辉.酮咯酸氨丁三醇联合舒芬太尼对腹腔镜胆囊切除术患者疼痛及血清应激指标的影响[J].中国临床研究,2025,38(12):1862-1866.

用微信扫一扫

用微信扫一扫